NSE BSE
ang lifesciences india limited stock

ANG Lifesciences India Limited Share Price

- - (%)
- NSE: ANG

ANG Lifesciences India Limited Share Price Update

As of the latest trading session, ANG Lifesciences India Limited share price is currently at 52.35, which is up by 0.14 from its previous closing. Today, the stock has fluctuated between 51.05 and 53.14. Over the past year, ANG Lifesciences India Limited has achieved a return of -23.70 %. In the last month alone, the return has been -3.10 %. Read More...

ANG Lifesciences India Limited Performance

Day Range

Low51.05 High53.14
52.38

52 Week Range

Low 44.49 High 86.06
52.38

ANG Lifesciences India Limited Share Price

540694

ANG

img img img img
No Data Available

Open Price

52.00

Prev. Close

52.20

Volume (Shares)

3059.00

Total traded value

1.60

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

ANG Lifesciences India Limited Fundamentals


(Standalone)

Market Cap (Cr) 68.36
PE Ratio (TTM) 0.00
Book Value / Share 59.02
Beta 0.07
ROE -0.46%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -3.60

ANG Lifesciences India Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 34.08
Operating Expense 35.51
Net Profit -3.60
Net Profit Margin (%) -10.56
Earnings Per Share (EPS) -2.73
EBITDA 2.36
Effective Tax Rate (%) -23.71
Particulars DEC 2023 (Values in Cr)
Revenue 17.10
Operating Expense 22.81
Net Profit -4.59
Net Profit Margin (%) -26.84
Earnings Per Share (EPS) -3.51
EBITDA -1.81
Effective Tax Rate (%) 21.13
Particulars SEP 2023 (Values in Cr)
Revenue 29.58
Operating Expense 32.19
Net Profit -2.05
Net Profit Margin (%) -6.93
Earnings Per Share (EPS) -1.53
EBITDA 1.65
Effective Tax Rate (%) 10.08
Particulars JUN 2023 (Values in Cr)
Revenue 50.61
Operating Expense 48.82
Net Profit 1.60
Net Profit Margin (%) 3.16
Earnings Per Share (EPS) 1.28
EBITDA 6.02
Effective Tax Rate (%) 25.23
Particulars MAR 2023 (Values in Cr)
Revenue 31.88
Operating Expense 47.40
Net Profit -5.03
Net Profit Margin (%) -15.77
Earnings Per Share (EPS) -3.95
EBITDA -2.40
Effective Tax Rate (%) 20.53
Particulars MAR 2024 (Values in Cr)
Revenue 131.37
Operating Expense 139.34
Net Profit -8.65
Net Profit Margin (%) -6.58
Earnings Per Share (EPS) -6.48
EBITDA 8.21
Effective Tax Rate (%) 2.48
Particulars MAR 2023 (Values in Cr)
Revenue 207.01
Operating Expense 214.76
Net Profit -0.66
Net Profit Margin (%) -0.31
Earnings Per Share (EPS) 0.04
EBITDA 20.91
Effective Tax Rate (%) 131.88
Particulars MAR 2022 (Values in Cr)
Revenue 348.67
Operating Expense 296.56
Net Profit 39.71
Net Profit Margin (%) 11.38
Earnings Per Share (EPS) 38.51
EBITDA 66.03
Effective Tax Rate (%) 25.16
Particulars MAR 2021 (Values in Cr)
Revenue 154.28
Operating Expense 145.16
Net Profit 7.25
Net Profit Margin (%) 4.69
Earnings Per Share (EPS) 12.63
EBITDA 15.68
Effective Tax Rate (%) 26.47
Particulars MAR 2020 (Values in Cr)
Revenue 126.83
Operating Expense 118.85
Net Profit 6.10
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 11.76
EBITDA 12.51
Effective Tax Rate (%) 27.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 62.43
ROE % -0.21
ROCE % 8.26
Total Debt to Total Equity 0.88
EBITDA Margin 10.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.28
ROE % 48.13
ROCE % 35.05
Total Debt to Total Equity 0.92
EBITDA Margin 19.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.91
ROE % -0.46
ROCE % 7.81
Total Debt to Total Equity 0.69
EBITDA Margin 9.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.00
ROE % 63.62
ROCE % 49.10
Total Debt to Total Equity 0.83
EBITDA Margin 19.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 76.99
ROE % 19.10
ROCE % 19.05
Total Debt to Total Equity 0.83
EBITDA Margin 10.42
Particulars MAR 2020 (Values in Cr)
Book Value / Share 66.67
ROE % 19.27
ROCE % 20.74
Total Debt to Total Equity 0.67
EBITDA Margin 10.13
Particulars MAR 2019 (Values in Cr)
Book Value / Share 55.50
ROE % 21.76
ROCE % 22.44
Total Debt to Total Equity 0.76
EBITDA Margin 9.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.17
Total Assets 279.70
Total Liabilities 279.70
Total Equity 86.21
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.09
Return on Capital (%) -0.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 291.03
Total Liabilities 291.03
Total Equity 83.76
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 13.85
Return on Capital (%) 25.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 252.50
Total Liabilities 252.50
Total Equity 85.53
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.26
Return on Capital (%) -0.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.58
Total Assets 268.68
Total Liabilities 268.68
Total Equity 83.48
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 14.78
Return on Capital (%) 27.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 142.24
Total Liabilities 142.24
Total Equity 41.35
Share Outstanding 5183315
Price to Book Ratio 1.11
Return on Assets (%) 5.09
Return on Capital (%) 8.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 94.07
Total Liabilities 94.07
Total Equity 34.55
Share Outstanding 5183315
Price to Book Ratio 0.45
Return on Assets (%) 6.47
Return on Capital (%) 11.56
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 4.37
Total Assets 80.89
Total Liabilities 80.89
Total Equity 28.76
Share Outstanding 5183315
Price to Book Ratio 0.86
Return on Assets (%) 6.98
Return on Capital (%) 11.9
Particulars MAR 2023 (Values in Cr)
Net Income 2.62
Cash from Operations 29.83
Cash from Investing -9.32
Cash from Financing -17.07
Net change in Cash -0.02
Free Cash Flow 40.28
Particulars MAR 2022 (Values in Cr)
Net Income 53.50
Cash from Operations 25.24
Cash from Investing -44.40
Cash from Financing 19.92
Net change in Cash 0.23
Free Cash Flow 66.58
Particulars MAR 2023 (Values in Cr)
Net Income 2.06
Cash from Operations 29.36
Cash from Investing -9.34
Cash from Financing -16.74
Net change in Cash -0.08
Free Cash Flow 39.80
Particulars MAR 2022 (Values in Cr)
Net Income 53.06
Cash from Operations 27.97
Cash from Investing -42.50
Cash from Financing 15.28
Net change in Cash 0.17
Free Cash Flow 67.31
Particulars MAR 2021 (Values in Cr)
Net Income 9.86
Cash from Operations -10.55
Cash from Investing -7.78
Cash from Financing 18.80
Net change in Cash -0.16
Free Cash Flow -6.48
Particulars MAR 2020 (Values in Cr)
Net Income 6.09
Cash from Operations 7.48
Cash from Investing -1.65
Cash from Financing -3.94
Net change in Cash -0.77
Free Cash Flow 9.12
Particulars MAR 2019 (Values in Cr)
Net Income 5.64
Cash from Operations 9.82
Cash from Investing -0.77
Cash from Financing -3.79
Net change in Cash 2.89
Free Cash Flow 10.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
ANG Lifesciences India Limited 52.20 0.00 0.89 68.16 44.49 / 86.06
BLISS GVS PHARMA LTD 115.55 12.63 1.25 1210.24 77.65 / 148.95
CIPLA LTD 1511.95 28.67 4.57 122092.68 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 198.30 0.00 2.01 583.62 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2570.85 66.33 24.49 43551.75 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ANG Lifesciences India Limited 52.20 0.00 0.88 68.16 44.49 / 86.06
AMRUTAJAN HEALTH LTD 751.75 48.31 7.53 2173.36 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6756.05 112.98 23.72 16890.13 3715.05 / 7550.00
BLISS GVS PHARMA LTD 115.55 15.89 1.22 1210.24 77.65 / 148.95
ABBOTT INDIA LIMITED 27481.60 48.62 15.78 58398.40 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 52.40
  • 26 Days 52.30
  • 10 Days 52.30
  • 50 Days 53.20
  • 12 Days 52.20
  • 100 Days 55.50
  • 20 Days 52.40
  • 200 Days 71.30
52.53
PIVOT
First Resistance 53.02
Second Resistance 53.84
Third Resistance 54.33
First Support 51.71
Second Support 51.22
Third Support 50.40
RSI 50.60
MACD -0.08
Commodity Channel Index (CCI) 27.17
ADX 26.52
Williams % R -64.12

Over 1 Month

down

-3.10

Over 3 Months

down

-8.00

Over 6 Months

down

-29.31

Over 1 Year

down

-23.70

Over 3 Years

down

-8.00

Over 5 Years

down

28.22

ANG Lifesciences India Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ANG Lifesciences India Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
29.39
Promoter Holdings
70.6
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
44.88
Name Category Shares Shares%
Rajesh Gupta Shareholding of Promoter and Promoter Group 9194537.0 70.41
Saruchi Gupta Shareholding of Promoter and Promoter Group 25000.0 0.19

ANG Lifesciences India Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-11-02 1.0 Interim 2021-11-04 Equity shares
Ex-Date Ex-Bonus Ratio
2022-07-14 2022-07-13 1:4 2021-09-23 2021-09-22 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ANG Lifesciences India Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ANG Lifesciences India Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of ANG Lifesciences India Ltd?

Answer Field

The share price of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and for BSE is ₹ 52.38.

What is the Market Cap of ANG Lifesciences India Ltd?

Answer Field

The market cap of ANG Lifesciences India Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 68.40 Cr. as of now.

What is the 52 Week High and Low of ANG Lifesciences India Ltd?

Answer Field

The 52 Week High and Low of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 86.06 and ₹ 44.49.

How to Buy ANG Lifesciences India Ltd share?

Answer Field

You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for ANG Lifesciences India Ltd?

Answer Field

The 1 year returns on the stock has been -23.70%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader